水滴公司一季度营收7.54亿元

Group 1 - The company reported a net operating revenue of 754 million yuan for Q1 2025, representing a year-on-year growth of 7% [1] - The net profit attributable to the parent company reached 108 million yuan, with a year-on-year increase of 34.2%, marking the 13th consecutive quarter of profitability [1] - Operating expenses, including sales, management, and R&D costs, accounted for 40.3% of revenue, a decrease of 6.1 percentage points year-on-year [1] Group 2 - Insurance-related revenue for the first quarter was 658 million yuan, showing a year-on-year growth of 8.4%, with an operating profit of 151 million yuan [1] - The first-year premium for the insurance business was 2.092 billion yuan, reflecting a year-on-year increase of 19.3% [1] Group 3 - The company's crowdfunding platform, which assists patients in urgent need, has seen approximately 475 million users donate a total of 68.8 billion yuan since its launch, with a Q1 operating loss of about 30.2 million yuan [3] - The digital clinical trial solutions business generated a net operating revenue of 23 million yuan in Q1 2025, an increase of 11.5% year-on-year, with partnerships established with 185 pharmaceutical companies and contract research organizations [3] - As of the end of March, the company had completed 1,281 projects and enrolled 11,217 patients [3]